These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1153619)

  • 1. Neurochemical and pharmacological studies on a new 5HT-uptake inhibitor, FG4963, with potential antidepressant properties.
    Lassen JB; Squires RF; Christensen JA; Molander L
    Psychopharmacologia; 1975 Apr; 42(1):21-6. PubMed ID: 1153619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative studies of a new 5HT-uptake inhibitor and some tricyclic thymoleptics.
    Lassen JB; Petersen E; Kjellberg B; Olsson SO
    Eur J Pharmacol; 1975 May; 32(1):108-15. PubMed ID: 1149822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 5HT uptake inhibitors on the pressor response to 5HT in the pithed rat. The significance of the 5HT blocking property.
    Petersen EN; Olsson SO; Squires RF
    Eur J Pharmacol; 1977 Jun; 43(3):209-15. PubMed ID: 872876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171.
    Hyttel J
    Psychopharmacology (Berl); 1977 Mar; 51(3):225-33. PubMed ID: 403537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant evaluation and the pharmacological actions of FG4963 in depressive patients.
    Ghose K; Gupta R; Coppen A; Lund J
    Eur J Pharmacol; 1977 Mar; 42(1):31-7. PubMed ID: 321228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential binding of antidepressants to noradrenaline and serotonin transport sites in central nerve endings.
    Raiteri M; Del Carmine R; Cervoni AM; Levi G
    Eur J Pharmacol; 1979 Aug; 57(4):407-16. PubMed ID: 488170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central and peripheral 5-HT uptake in rats treated chronically with femoxetine, paroxetine, and chlorimipramine.
    Lassen JB; Lund J; Søndergaard I
    Psychopharmacology (Berl); 1980; 68(3):229-33. PubMed ID: 6446724
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacology of lortalamine, a new potent non-tricyclic antidepressant.
    Depin JC; Betbeder-Matibet A; Bonhomme Y; Muller AJ; Berthelon JJ
    Arzneimittelforschung; 1985; 35(11):1655-62. PubMed ID: 4091869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some biochemical properties of the new potential antidepressant agent N-methyl-N-propargyl-2-(1-methyl-5-methoxyindolyl)methylamine.
    Carranza Gómez-Carpintero M; Ochoa Estomba MC
    Arzneimittelforschung; 1993 Sep; 43(9):937-41. PubMed ID: 8240453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparison of fluoxetine and nisoxetine with tricyclic antidepressants in blocking the neurotoxicity of p-chloroamphetamine and 6-hydroxydopamine in the rat brain.
    Wong DT; Bymaster FP
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):221-31. PubMed ID: 981783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine.
    Wong DT; Bymaster FP; Horng JS; Molloy BB
    J Pharmacol Exp Ther; 1975 Jun; 193(3):804-11. PubMed ID: 1151730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CGP 6085 A, a new, specific, inhibitor of serotonin uptake: neurochemical characterization and comparison with other serotonin uptake blockers.
    Waldmeier PC; Baumann PA; Maítre L
    J Pharmacol Exp Ther; 1979 Oct; 211(1):42-9. PubMed ID: 490325
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor.
    Thomas DR; Nelson DR; Johnson AM
    Psychopharmacology (Berl); 1987; 93(2):193-200. PubMed ID: 2962217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Specific inhibitory action of a novel antidepressant paroxetine on 5-HT uptake].
    Tanigaki N; Manno K; Sugihara K; Miki N; Ichida S; Yoshida H
    Nihon Yakurigaku Zasshi; 1987 Apr; 89(4):175-80. PubMed ID: 3038714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxylated metabolites of tricyclic antidepressants: preclinical assessment of activity.
    Potter WZ; Calil HM; Manian AA; Zavadil AP; Goodwin FK
    Biol Psychiatry; 1979 Aug; 14(4):601-13. PubMed ID: 486616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative.
    Muth EA; Haskins JT; Moyer JA; Husbands GE; Nielsen ST; Sigg EB
    Biochem Pharmacol; 1986 Dec; 35(24):4493-7. PubMed ID: 3790168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tandamine and pirandamine, new potential antidepressants, on the brain uptake of norepinephrine and 5-hydroxytryptamine and related activities.
    Pugsley T; Lippmann W
    Psychopharmacology (Berl); 1976 May; 47(1):33-41. PubMed ID: 1085452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the new 5-HT-uptake inhibitor paroxetine on hypermotility in rats produced by p-chloroamphetamine (PCA) and 4,alpha-dimethyl-7-tyramine (H 77/77).
    Lassen JB
    Psychopharmacology (Berl); 1978 Apr; 57(2):151-3. PubMed ID: 418448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Du 24565, a quipazine derivative, a potent selective serotonin uptake inhibitor.
    Vaatstra WJ; Deiman-Van Aalst WM; Eigeman L
    Eur J Pharmacol; 1981 Mar; 70(2):195-202. PubMed ID: 6973481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the regional and specific serotonin uptake inhibition by LM 5008.
    Le Fur G; Kabouche M; Uzan A
    Life Sci; 1978 Nov; 23(19):1959-65. PubMed ID: 310012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.